Dofetilide and Dibenzepin: Interaction Details
- Dofetilide
- Tikosyn
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Dofetilide and Dibenzepin interaction:
Dibenzepin
We don't have a drug information page for Dibenzepin yet. Have a question about Dibenzepin? Ask a pharmacist, free →
What Happens When You Take Dofetilide With Dibenzepin
What can happen when they are taken together (rated Major)
An increased risk of (, , cardiac arrest)
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Reports of QTc prolongation and/or torsades de pointes exist for every Class III antiarrhythmic agent, among them acecainide,4 amiodarone,5 azimilide,6 bretylium,7 ibutilide,8 sematilide,9 dofetilide,1 and sotalol.10 No formal drug interaction studies have been conducted. Even so, giving a Class III antiarrhythmic together with other drugs known to prolong the , included, is not recommended.211
The Dofetilide and Dibenzepin Interaction, Explained
Dofetilide (Tikosyn) is a heart rhythm medicine, and dibenzepin is an older antidepressant in the tricyclic family. Both can stretch out the heart's electrical recharge time, called the . Together, that effect can add up and raise the chance of a dangerous rhythm problem called .
This warning is based on how the drugs work rather than on studies of these two together, but it is still taken seriously because the heart effects can be sudden. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor, who can review your options and manage this safely.
Mechanism: . Dofetilide (a Class III antiarrhythmic, IKr/hERG blocker) combined with dibenzepin (a with QT-prolonging potential) may increase the risk of and cardiac arrest. This is a interaction, not a PK one.
- Evidence: theoretical, no formal interaction studies; class-based concern.
- Onset: rapid. Severity: major.
- Management: of a Class III antiarrhythmic and a TCA is not recommended. Consider alternatives, and if the combination is unavoidable, use / monitoring and correct potassium and magnesium.
See the 11 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Dofetilide and Dibenzepin Interact
The likely mechanism
How to Manage the Dofetilide and Dibenzepin Interaction
The documented advice is that this combination is not recommended, so your care team will usually look at whether one of the medicines can be replaced with an alternative that has less effect on heart rhythm.
- Don't stop or change either medicine on your own. Stopping suddenly can cause its own problems.
- Tell your pharmacist and prescriber that you take both, including any other medicines or supplements.
- If your team decides both are needed, they may monitor you more closely.
- Seek urgent help for fainting, a racing or irregular heartbeat, or severe dizziness.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Dofetilide or Dibenzepin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications
In patients given at therapeutic doses, reported changes include a faster heart rate, a longer PR interval, intraventricular conduction delays, a longer corrected (), and flattened T waves.3
-
Report 2 · Study title
Potentially significant drug interactions of class III antiarrhythmic drugs
Using Class III antiarrhythmic agents together with other drugs that can prolong the , such as , is not recommended. Dofetilide should be discontinued for a minimum of 2 days before any interacting drug is started. When cannot be avoided, careful dosing and telemetric monitoring are advised.2
Dofetilide and Dibenzepin: Common Questions
How serious is the Dofetilide and Dibenzepin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Dofetilide and Dibenzepin interaction managed?
The documented advice is that this combination is not recommended, so your care team will usually look at whether one of the medicines can be replaced with an alternative that has less effect on heart rhythm. Don't stop or change either medicine on your own. Stopping suddenly can cause its own problems. Tell your pharmacist and prescriber that you take both, including any other medicines or supple… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Dofetilide and Dibenzepin Interaction
Ask in your own words about taking Dofetilide and Dibenzepin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (11)
- Allen MJ, Oliver SD, Newgreen MW, et al: Pharmacodynamic effect of continuous vs intermittent dosing of dofetilide on QT interval. Br J Clin Pharmacol 2002; 53:59-65.
- Yamreudeewong W, DeBisschop M, Martin LG, et al: Potentially significant drug interactions of class III antiarrhythmic drugs. Drug Safety 2003; 26(6):421-438. PubMed
- Marshall JB & Forker AD: Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications. Am Heart J 1982; 103:401-414. PubMed
- Chow MJ, Piergies AA, Bowsher DJ, et al: Torsade de pointes induced by N-acetylprocainamide. J Am Coll Cardiol 1984; 4:621-624. DOI
- Faggiano P, Gardini A, D'Aloia A, et al: Torsade de pointes occurring early during oral amiodarone treatment. Int J Cardiol 1996; 55(2):205-208. PubMed
- Corey AE, Agnew JR, Valentine SN, et al: Azimilide pharmacokinetics following intravenous and oral administration of a solution and capsule formulation. J Clin Pharmacol 1999; 39(12):1272-1276. PubMed
- Gilman AG, Goodman LS, Rall TW, et alGilman AG, Goodman LS, Rall TW, et al (Eds): The Pharmacological Basis of Therapeutics, 7th. Macmillan Publishing Co, New York, NY, 1985.
- Rodriguez I, Kilborn MJ, Liu XK, et al: Drug-induced QT prolongation in women during the menstrual cycle. JAMA 2001; 285(10):1322-1326. PubMed
- Singh BN: The coming of age of the class III antiarrhythmic principle: retrospective and future trends. Am J Cardiol 1996; 78(suppl):17-27. DOI
- Marill KA & Runge T: Meta-analysis of the risk of torsades de pointes in patients treated with intravenous racemic sotalol. Acad Emerg Med 2001; 8(2):117-124. PubMed
- Product Information: Corvert(R), ibutilide fumarate injection. Pharmacia & Upjohn Company, Kalamazoo, MI, 2000. DailyMed
Other Serious Interactions of Dofetilide and Dibenzepin
Also serious with Dibenzepin
- Metoclopramide InjectionContraindicated
- Metoclopramide Nasal SprayContraindicated
- IsocarboxazidContraindicated
- MetoclopramideContraindicated
Also serious with Dofetilide
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Dofetilide
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- + 143 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.